FT-MS, Quantitation, Modifications, Antibodies Buzzwords in 2003: Will Continue in 2004 | GenomeWeb

Many will remember 2003 as the year of biomarker hype and hope, but as a several researchers in the field told ProteoMonitor this month, biomarkers were not the only show in town — nor are they the only story to look for in 2004. Fourier-transform mass specs, an increased emphasis on quantitation and post-translational modifications, as well as the mass production of antibodies also featured prominently in 2003, and are slated to continue to play a central role in 2004.

FT-MS: here today, still here at ASMS?

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.